NCT00315640 - Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Eye Diseases

Interventions

DRUG

Anecortave Acetate Sterile Suspension, 6 mg/mL

One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye

DRUG

Anecortave Acetate Suspension Depot, 30 mg/mL

One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye

DRUG

Anecortave Acetate Sterile Suspension, 60 mg/mL

One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye

OTHER

Anecortave Acetate Vehicle

One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye

Trial Locations (12)

Jacksonville, Jacksonville

Miami, Miami

Detroit, Detroit

Fort Worth

Houston, Houston

San Paulo, São Paulo

Budapest, Budapest

Padova, Padua

Amsterdam, Amsterdam

Barcelona, Barcelona

Newcastle upon Tyne, Newcastle upon Tyne

Bayamon, Bayamón